ARK Genomic Revolution ETF (ARKG)
ARK Investment Management LLC
- Page updated:
- Sep 7, 2026
- Data as of:
- Jun 30, 2026
Fund identity
- Ticker
- ARKG
- Fund name
- ARK Genomic Revolution ETF
- Fund type
- ETF
- Listing venue
- Cboe BZX
- Currency
- USD
- Domicile
- US
- Inception
- Oct 31, 2014
Structure and strategy
- Sponsor
- ARK Investment Management LLC
- Management approach
- Active
- Strategy
- Actively invests in companies expected to benefit from the genomics revolution, including precision therapies, multiomics and programmable biology.
- Portfolio scope
- Innovation-oriented equities relevant to genomic technologies and related enabling technologies
- Portfolio implementation
- Active thematic equity management
- Asset class
- Equity
- Category
- Genomic Innovation
Costs and minimums
- Total fees
- 0.75%
- Ongoing fee as of
- Jun 30, 2026
Size and distributions
- Assets under management
- $1.73B
- Assets under management scope
- Fund
Sources
- ARK Genomic Revolution ETF — issuer product page — ARK Investment Management · data as of Sep 7, 2026
Learn the basics
ROIStreet publishes this reference data for education and research. Figures are as of the dates shown, are not real-time quotes, and are not investment advice. Verify details with the issuer or provider before acting.